Skip to main content
. Author manuscript; available in PMC: 2024 Oct 1.
Published in final edited form as: Transplantation. 2023 Jun 8;107(10):2255–2261. doi: 10.1097/TP.0000000000004672

Table 3.

Participant characteristics stratified by frailty status

Overall Never Frail Ever Frail P value

No. of subjects 231 119 112
Male, No. (%) 127 (55.0) 78 (65.5) 49 (43.8) 0.001
Age, mean ± SD 55.7 ± 12.1 53.8 ± 12.9 57.7 ± 10.9 0.016
Age, No. (%)
 < 35 years 20 (8.7) 13 (10.9) 7 (6.3) 0.006
 35–49 years 41 (17.8) 30 (25.2) 11 (9.8)
 50–64 years 111 (48.1) 49 (41.2) 62 (55.4)
 ≥65 years 59 (25.5) 27 (22.7) 32 (28.6)
Race, No. (%)
 White 165 (71.4) 85 (71.4) 80 (71.4) 0.611
 Black 19 (8.2) 8 (6.7) 11 (9.8)
 Asian 11 (4.8) 8 (6.7) 3 (2.7)
 Hispanic 32 (13.9) 16 (13.4) 16 (14.3)
 Other 4 (1.7) 2 (1.7) 2 (1.8)
Diagnosis, No. (%)
 A (e.g. Obstructive lung disease) 37 (16.0) 11 (9.2) 26 (23.2) 0.008
 B (e.g. Pulmonary Hypertension) 10 (4.3) 6 (5.0) 4 (3.6)
 C (e.g. Suppurative lung disease) 20 (8.7) 15 (12.6) 5 (4.5)
 D (e.g. Pulmonary Fibrosis) 164 (71.0) 87 (73.1) 77 (68.8)
BMI (kg/m2), mean ± SD 25.5 ± 4.4 25.0 ± 4.3 26.1 ± 4.3 0.063
FEV1 % predicted, mean ± SD 45.4 ± 20.5 45.9 ± 20.5 44.9 ± 20.5 0.715
FEV1 % predicted, median (Q1, Q3) 46.0 (28.0, 60.0) 45.5 (28.0, 60.0) 46.0 (29.0, 59.0) 0.821
6 MWD (m), mean ± SD 254.4 ± 140.8 275.8 ± 136.3 231.2 ± 142.5 0.017
6 MWD (m), median (Q1, Q3) 268.2 (142.7, 366.0) 303.9 (159.0, 376.0) 228.6 (134.2, 332.5) 0.007
LAS at transplant, mean ± SD 58.5 ± 21.5 57.4 ± 20.3 59.7 ± 22.6 0.413
LAS at transplant, median (Q1, Q3) 52.0 (39.0, 79.0) 50.0 (41.0, 72.0) 55.0 (38.5, 84.5) 0.750
Transplant type, No. (%)
 Bilateral 215 (93.1) 106 (89.1) 109 (97.3) 0.022
 Single 13 (5.6) 11 (9.2) 2 (1.8)
 Heart/Lung 3 (1.3) 2 (1.7) 1 (0.9)
Inpatient at transplant, No. (%) 76 (32.9) 35 (29.4) 41 (36.6) 0.245
Ventilator at transplant, No. (%) 21 (9.1) 13 (10.9) 8 (7.1) 0.317
ECMO at transplant, No. (%) 18 (7.8) 11 (9.2) 7 (6.3) 0.396
Pre-transplant SPPB, mean ± SD 9.0 ± 3.1 9.7 ± 2.9 8.1 ± 3.0 <0.001
Pre-transplant SPPB, median (Q1, Q3) 10.0 (8.0, 11.0) 11.0 (9.0, 12.0) 9.0 (7.0, 10.0) <0.001
Time to CLAD, years, median (Q1, Q3) 2.9 (1.6, 4.5) 3. 0 (1.8, 4.8) 2.7 (1.2, 4.5) 0.328